| scholarly article | Q13442814 |
| P50 | author | Richard G Gorlick | Q56427012 |
| P2093 | author name string | Bang H Hoang | |
| David S Geller | |||
| Xingxing Zang | |||
| Jonathan Gill | |||
| Sajida Piperdi | |||
| Pratistha Koirala | |||
| Michael E Roth | |||
| Jordan M Chinai | |||
| Maya Ghorpade | |||
| Michelle R Ewart | |||
| Yekaterina V Fatakhova | |||
| P2860 | cites work | Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients | Q82929476 |
| Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma | Q37109503 | ||
| Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma | Q37125088 | ||
| Chromothripsis: chromosomes in crisis | Q38059925 | ||
| Translational biology of osteosarcoma | Q38260633 | ||
| Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions. | Q38902256 | ||
| Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma | Q39956327 | ||
| Endogenous retroviruses provide the primary polyadenylation signal for two new human genes (HHLA2 and HHLA3). | Q40936070 | ||
| Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy | Q41983246 | ||
| Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma | Q42874163 | ||
| HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families | Q43245544 | ||
| Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy | Q44667120 | ||
| B7-H5 costimulates human T cells via CD28H | Q24295841 | ||
| Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis | Q24307624 | ||
| Massive genomic rearrangement acquired in a single catastrophic event during cancer development | Q24631164 | ||
| Evaluation of eIF4E expression in an osteosarcoma-specific tissue microarray | Q24635844 | ||
| PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
| Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
| Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
| Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program | Q33406382 | ||
| Programmed cell death ligand 1 expression in osteosarcoma | Q33848154 | ||
| Neoantigens in cancer immunotherapy. | Q34470074 | ||
| Osteosarcoma: a review of diagnosis, management, and treatment strategies | Q34626942 | ||
| The molecular pathogenesis of osteosarcoma: a review | Q34629074 | ||
| Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma | Q34793401 | ||
| Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. | Q34809019 | ||
| A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2. | Q35612992 | ||
| Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein | Q35613102 | ||
| Objective measurement and clinical significance of TILs in non-small cell lung cancer | Q36047422 | ||
| HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function | Q36932447 | ||
| The B7 family and cancer therapy: costimulation and coinhibition | Q36944386 | ||
| Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC. | Q37007501 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 31154 | |
| P577 | publication date | 2016-08-17 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival | |
| P478 | volume | 6 |
| Q91738964 | Association of high PDPN expression with pulmonary metastasis of osteosarcoma and patient prognosis |
| Q61814936 | B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma |
| Q89475415 | B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling |
| Q90281737 | CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7+ Tumor Cells |
| Q90207349 | CD28 family of receptors inter-connect in the regulation of T-cells |
| Q89589912 | Comprehensive molecular profiling of the B7 family in gastrointestinal cancer |
| Q92782141 | HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma |
| Q64080810 | HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 |
| Q93187257 | HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival |
| Q90442569 | HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma |
| Q90269754 | HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer |
| Q64250330 | Macrophages from Susceptible and Resistant Chicken Lines have Different Transcriptomes following Marek's Disease Virus Infection |
| Q39416195 | New B7 Family Checkpoints in Human Cancers |
| Q92344203 | New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies? |
| Q92292617 | Overexpression of B7H5/CD28H is associated with worse survival in human gastric cancer |
| Q64107489 | Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients |
| Q53834241 | Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma |
| Q55240839 | The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis. |
| Q38684886 | The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1. |
| Q39160982 | The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3. |
| Q48158394 | Wide expression and significance of alternative immune checkpoint molecules, B7x and HHLA2, in PD-L1 negative human lung cancers. |
Search more.